Anti-Human LOXL2 Recombinant Antibody
-
产品编号
YR1290
-
别名
科研级 Simtuzumab ( 辛妥珠单抗 ), Anti-LOXL2 Recombinant Antibody, Research Grade Simtuzumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Simtuzumab ( 辛妥珠单抗 ), Anti-LOXL2 Recombinant Antibody, Research Grade Simtuzumab |
Catalog Number | YR1290 |
Molecular Name | Simtuzumab |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG4 Kappa |
Formulation | PBS, pH7.5 |
Background | Simtuzumab (INN, formerly GS 6624) is a humanized monoclonal antibody designed for the treatment of fibrosis. It binds to LOXL2 and acts as an immunomodulator. In January 2016, Gilead Sciences terminated its Phase 2 clinical study in patients with idiopathic pulmonary fibrosis (IPF) due to lack of efficacy. |
CAS Number | 1318075-13-6 |
Application | FCM, IP, ELISA, Neut, FuncS |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | LOXL2[Homo sapiens] |